Estia Health Limited
AU:
EHE
-
AUD
MEDICAL CARE FACILITIES
A$2.27
0.00%
How to buy Estia Health (EHE) shares
Learn how to easily invest in Estia Health shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Estia Health Limited is a medical care facilities business based in Australia. Estia Health shares (EHE) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Estia Health has a trailing 12-month revenue of around $646.3 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Estia Health
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Estia Health. Find the share by name or ticker symbol: EHE. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Estia Health reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Estia Health. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
What's in this guide?
Estia Health stock price (ASX:EHE)
Use our graph to track the performance of EHE stocks over time.Estia Health shares at a glance
Information last updated 2021-09-25.
| 52-week range | $1.2626 - $2.7133 |
|---|---|
| 50-day moving average | $2.3361 |
| 200-day moving average | $2.3559 |
| Target price | $2.45 |
| PE ratio | 98.6957 |
| Dividend yield | $0.023 (1.01%) |
| Earnings per share (TTM) | $0.023 |
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Is it a good time to buy Estia Health stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Estia Health price performance over time
Historical closes compared with the last close of A$2.27
| 1 week (2021-09-17) | -8.84% |
|---|---|
| 1 month (2021-08-25) | -1.73% |
| 3 months (2021-06-25) | -11.33% |
| 6 months (2021-03-25) | 6.07% |
| 1 year (2020-09-25) | 62.14% |
|---|---|
| 2 years (2019-09-25) | -10.98% |
| 3 years (2018-09-25) | -5.42% |
| 5 years (2016-09-23) | -31.63% |
Is Estia Health under- or over-valued?
Valuing Estia Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Estia Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Estia Health's P/E ratio
Estia Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 99x. In other words, Estia Health shares trade at around 99x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Estia Health's EBITDA
Estia Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $101.1 million (£0.0 million).
The EBITDA is a measure of a Estia Health's overall financial performance and is widely used to measure a its profitability.
Estia Health financials
| Revenue TTM | $646.3 million |
|---|---|
| Operating margin TTM | 9.81% |
| Gross profit TTM | $141.1 million |
| Return on assets TTM | 2.12% |
| Return on equity TTM | 0.98% |
| Profit margin | 0.93% |
| Book value | 2.356 |
| Market capitalisation | $593.5 million |
TTM: trailing 12 months
Estia Health share dividends
Dividend payout ratio: 28.75% of net profits
Recently Estia Health has paid out, on average, around 28.75% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.01% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Estia Health shareholders could enjoy a 1.01% return on their shares, in the form of dividend payments. In Estia Health's case, that would currently equate to about A$0.023 per share.
While Estia Health's payout ratio might seem fairly standard, it's worth remembering that Estia Health may be investing much of the rest of its net profits in future growth.
The latest dividend was paid out to all shareholders who bought their shares by 26 August 2021 (the "ex-dividend date").
Estia Health share price volatility
Over the last 12 months, Estia Health's shares have ranged in value from as little as $1.2626 up to $2.7133. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Estia Health's is 1.4156. This would suggest that Estia Health's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Estia Health overview
Estia Health Limited provides services in residential aged care homes in Australia. The company operates residential aged care homes. As of June 30, 2021, it had 69 homes of which 62 are freehold sites that include 6,289 operational bed licenses in New South Wales, Queensland, South Australia, and Victoria. The company was founded in 2005 and is based in Sydney, Australia.
Stocks similar to Estia Health
Estia Health in the news
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
How to invest in the Cosmos Exploration IPO
Everything we know about the Cosmos Exploration IPO, plus information on how to buy in.
-
What is behind the bounce in the Zip Co share price?
Shares in BNPL provider Zip Co have slipped more than 13% in the last 6 months.
-
Why the AGL share price has rebounded today
Shares in electricity giant AGL Energy are down 60% in the last 12 months.
-
How to invest in the Dundas Minerals IPO
Everything we know about the Dundas Minerals IPO, plus information on how to buy in.
-
How to invest in the Kalgoorlie Gold Mining IPO
Everything we know about the Kalgoorlie Gold Mining IPO, plus information on how to buy in.
-
The best iron ore stocks on the ASX (2021)
We look at some of the biggest and best performing iron ore stocks in Australia.
-
Why are the CBA and WBC share prices stumbling today?
Shares in the major banks have risen more than 50% in the last 12 months.
-
How to buy Evergrande shares from Australia
Steps to owning and managing China Evergrande Group shares from Australia.
-
How to invest in the Hamelin Gold IPO
Everything we know about the Hamelin Gold IPO, plus information on how to buy in.
-
How to invest in the Lykos Metals IPO
Everything we know about the Lykos Metals IPO, plus information on how to buy in.
Ask an Expert
